Join Now

Author Archives: Press Release

VIA CAPITAL announces the launch of Tailwind Business Accelerator

By Press Release | Published August 19, 2021

Tailwind Business Accelerator is giving $50,000 in cash and services to at least 5 companies in its first cohort, starting November 1. Applications close September 17 for this first cohort.

Posted in BioUtah News | Tagged , | Leave a comment

Genomics 101 by Intermountain Precision Genomics

By Press Release | Published August 19, 2021

In a recent article published by Utah Business Magazine, Dr. Lincoln Nadauld, Chief of Precision Health at Intermountain Healthcare, provides an explanation of the genomic world and how precision medicine will be evolving in the future. Intermountain Precision Genomics, a BioUtah member, is located in St. George, Utah and is a world leader in genomics.

Posted in BioUtah News | Tagged , | Leave a comment

Recursion Reports Second Quarter 2021 Financials and Provides Business Updates

By Press Release | Published August 19, 2021

Recursion, a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, today reported financial results and business updates for its second quarter ending June 30, 2021.

Posted in BioUtah News | Tagged | Leave a comment

CenExel Clinical Research Acquires Advanced Memory Research Institute

By Press Release | Published August 19, 2021

CenExel announces the acquisition of Advanced Memory Research Institute (“CenExel AMRI”), the largest Alzheimer’s Disease clinical research site in the Northeast. CenExel AMRI conducts Phase I through Phase IV studies, primarily in Alzheimer’s Disease, Memory Loss, and Dementia research.

Posted in BioUtah News | Tagged | Leave a comment

U.S. SKI & SNOWBOARD CHOOSES R-ZERO AS ITS BIOSAFETY PARTNER TO PROTECT ATHLETES AND STAFF

By Press Release | Published August 19, 2021

U.S. Ski & Snowboard joins the growing list of professional sports organizations, including NBA and NFL teams, using R-Zero’s tech to reduce health risks from COVID-19 and other airborne and surface pathogens

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results

By Press Release | Published August 12, 2021

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the second quarter ended June 30, 2021.

Posted in BioUtah News | Leave a comment

PolarityTE Reports Second Quarter Financial Results

By Press Release | Published August 12, 2021

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today provided a business update and reported financial results for the second quarter ended June 30, 2021.

Posted in BioUtah News | Leave a comment

Cytiva acquires Intermountain Life Sciences

By Press Release | Published August 12, 2021

Global life sciences leader Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain’s manufacturing site in Utah to rapidly boost its liquid cell culture production by millions of liters. Hiring is ongoing to rapidly increase output.

Posted in BioUtah News | Leave a comment

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021

By Press Release | Published August 5, 2021

The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results were the low point of Utah Medical Products, Inc.’s (Nasdaq: UTMD) performance during the COVID-19 pandemic, during a time when there were restrictions on so-called nonessential medical procedures. Therefore, UTMD management reports quarterly income statement results compared to the same periods not only in 2021 compared to 2020, but also compared to 2019. The Company’s stated objective in 2021 has been to try to fully recover back to its 2019 financial performance. Please see the income statements for all three years on the last page. 

Posted in BioUtah News, Press Releases | Tagged , | Leave a comment

CenExel Clinical Research Acquires ForCare Clinical Research

By Press Release | Published August 5, 2021

CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of ForCare Clinical Research (“CenExel FCR”), a Tampa-based clinical research organization with Principal Investigators who have more than 40 years of combined research experience. CenExel FCR conducts Phase I through Phase IV studies in both chronic and acute conditions, primarily in Dermatology

Posted in BioUtah News, Press Releases | Tagged , | Leave a comment

BIOMERICS ANNOUNCES ACQUISITION OF BERG MANUFACTURING INC. & KNIGHT MACHINING LLC.

By Press Release | Published August 5, 2021

Biomerics LLC, a leading mid-market contract manufacturer for the interventional medical device market, announced it has acquired a majority interest in Berg Manufacturing Inc. Berg Manufacturing, based in Santa Clara, California, is an industry leader in Swiss micromachining for the advanced robotic surgery, endoscope, and interventional catheter markets.

Posted in BioUtah News, Press Releases | Tagged , , | Leave a comment

Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries

By Press Release | Published August 3, 2021

Advancing its mission to expand access to genetic testing, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today launched a new version of its market-leading MyRisk Hereditary Cancer Test. For the first time, women of all ancestries can now receive a personalized polygenic breast cancer risk assessment together with the market’s most accurate hereditary cancer test.

Posted in BioUtah News, Press Releases | Tagged | Leave a comment

A Special Thanks To Our Elite Members